Contact Us|Terms of Use|Privacy Notice|Consumer Health Data Privacy Notice|Cookies Settings|Your Privacy Choices The product information provided in this site is intended only for consumers in the United States. The products discussed on this site may have different product labeling outside of the ...
The adverse reactions that were reported in at least 5% of patients in the 12-48 week open-label study to identify responders to enroll in Study B are listed in Table 3: Table 3: 12-48 Week Open Label Lead-In study to Study B Commonly Reported Adverse Reactions with a Frequency ≥ 5%...